Submitted in 2010, with no testing proposals, this substance has not undergone any aspect of the REACH evaluation process to date.

However, because of its solubility and bioavailability, this substance is often the test material choice for most academic studies which end up being published in peer-review literature. The outcome of these publications can change the hazard assessment of the dossier. Hence, Literature review is carried every two years. Furthermore, new information on two reproductive endpoints (two generation reproductive toxicity and pre-natal developmental toxicity) are available from the International Manganese Institute (IMnI) worker safety program. Both studies used MnCl2 as the test material. Therefore, the information from the published literature and from those studies developed by the IMnI triggered a spontaneous dossier update. 

The dossier was submitted earlier this year (2019) with new available data, in alignment with post 2010 ECHA guidance documents and the post 2010 CLP adaptations requirements. All co-registrants that had met their financial obligations were provided with the following:

1) Updated CSR

2) Exposure scenarios for their eSDS

3) Updated CLP classification.

An SDS temeplate has been prepared (Q3, 2019) for industry's use. This can be provided to you upon request - contact reach@manganese.org

Note: Post 2018, the consortium will no longer invoice co-registrants  for ECHA requested studies retrospectively. All compliance check related work will require co-registrants to contribute their share before any dossier update work can begin.